![Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.2016.92/MediaObjects/41379_2016_Article_BFmodpathol201692_Fig4_HTML.jpg)
Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology
![Utility of flow cytometry and gene rearrangement analysis in tissue and blood of patients with suspected cutaneous T‑cell lymphoma Utility of flow cytometry and gene rearrangement analysis in tissue and blood of patients with suspected cutaneous T‑cell lymphoma](https://www.spandidos-publications.com/article_images/or/45/1/OR-45-01-0349-g00.jpg)
Utility of flow cytometry and gene rearrangement analysis in tissue and blood of patients with suspected cutaneous T‑cell lymphoma
![Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.2016.92/MediaObjects/41379_2016_Article_BFmodpathol201692_Fig1_HTML.jpg)
Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine | Modern Pathology
![Prioritising primary care patients with unexpected weight loss for cancer investigation: diagnostic accuracy study | The BMJ Prioritising primary care patients with unexpected weight loss for cancer investigation: diagnostic accuracy study | The BMJ](https://www.bmj.com/content/bmj/370/bmj.m2651/F4.large.jpg)
Prioritising primary care patients with unexpected weight loss for cancer investigation: diagnostic accuracy study | The BMJ
![Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case–control study in patients aged ≤50 years | British Journal of General Practice Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case–control study in patients aged ≤50 years | British Journal of General Practice](https://bjgp.org/content/bjgp/72/721/e546/F2.large.jpg)
Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case–control study in patients aged ≤50 years | British Journal of General Practice
Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies | Haematologica
![Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention | Science Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention | Science](https://www.science.org/cms/asset/e5d79d60-4484-4bf3-8756-d7d8fea7c542/369_abb9601_fa.gif)
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention | Science
Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies | Haematologica
![Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case–control study in patients aged ≤50 years | British Journal of General Practice Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case–control study in patients aged ≤50 years | British Journal of General Practice](https://bjgp.org/content/bjgp/72/721/e546/F1.large.jpg)
Inflammatory marker testing in primary care in the year before Hodgkin lymphoma diagnosis: a UK population-based case–control study in patients aged ≤50 years | British Journal of General Practice
![Utility of Routine Surveillance Laboratory Testing in Detecting Relapse in Patients With Classic Hodgkin Lymphoma in First Remission: Results From a Large Single-Institution Study | JCO Oncology Practice Utility of Routine Surveillance Laboratory Testing in Detecting Relapse in Patients With Classic Hodgkin Lymphoma in First Remission: Results From a Large Single-Institution Study | JCO Oncology Practice](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/op/2020/op.2020.16.issue-9/jop.19.00733/20200904/images/large/jop.19.00733t2.jpeg)